Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 10
Submit an article Journal homepage
391
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Discontinued drugs in 2012: endocrine and metabolic

Jerry R ColcaMetabolic Solutions Development Co., 161 E. Michigan Ave, 4th Floor, Kalamazoo, MI 49007, USA+1 269 267 3567; [email protected]
, PhD
Pages 1305-1313 | Published online: 21 Aug 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Pradip D Patil, Umesh B Mahajan, Kalpesh R Patil, Sandip Chaudhari, Chandragouda R Patil, Yogeeta O Agrawal, Shreesh Ojha & Sameer N Goyal. (2017) Past and current perspective on new therapeutic targets for Type-II diabetes. Drug Design, Development and Therapy 11, pages 1567-1583.
Read now
Jerry R Colca. (2015) Discontinued drug therapies to treat diabetes in 2014. Expert Opinion on Investigational Drugs 24:9, pages 1241-1245.
Read now
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo & Guglielmo Borgia. (2015) Discontinued drugs in 2012 – 2013: hepatitis C virus infection. Expert Opinion on Investigational Drugs 24:2, pages 239-251.
Read now

Articles from other publishers (1)

Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa & Hong Liu. (2016) Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chemical Reviews 116:2, pages 422-518.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.